Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 26 Artikel )

03.07.2020 | Review | Ausgabe 2/2020

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?

Kristen D. Whitaker, Deepa Sheth, Olufunmilayo I. Olopade

10.07.2020 | Review | Ausgabe 2/2020

Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound

Aubriana M. McEvoy, Steven Poplack, Katelin Nickel, Margaret A. Olsen, Foluso Ademuyiwa, Imran Zoberi, Elizabeth Odom, Jennifer Yu, Su-Hsin Chang, William E. Gillanders

13.07.2020 | Review | Ausgabe 2/2020

Spatial location of local recurrences after mastectomy: a systematic review

Orit Kaidar-Person, Philip Poortmans, Birgitte Vrou Offersen, Sabine Siesling, Miri Sklair-Levy, Icro Meattini, Dirk de Ruysscher, Thorsten Kühn, Liesbeth J. Boersma

15.07.2020 | Review | Ausgabe 2/2020

TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin

Huayan Ren, Xiaoyi Mi, Pengyuan Zhao, Xueyan Zhao, Na Wei, Huifen Huang, Zhongqin Meng, Junna Kou, Mingfang Sun, Yuqiong Liu, Hongyan Zhang, Jianping Yang, Wencai Li, Huixiang Li

20.07.2020 | Review | Ausgabe 2/2020

Patient preferences for locoregional therapy in early-stage breast cancer

Christina A. Minami, Tari A. King, Elizabeth A. Mittendorf

07.07.2020 | Preclinical study | Ausgabe 2/2020

Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer

Albina Stocker, Andreas Trojan, Constanze Elfgen, Marie-Louis Hilbers, Linda Moskovszky, Zsuzsanna Varga

07.07.2020 | Preclinical study | Ausgabe 2/2020 Open Access

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy

Kai Li, Ning Liao, Bo Chen, Guochun Zhang, Yulei Wang, Liping Guo, Guangnan Wei, Minghan Jia, Lingzhu Wen, Chongyang Ren, Li Cao, Hsiaopei Mok, Cheukfai Li, Jiali Lin, Xiaoqing Chen, Zhou Zhang, Ting Hou, Min Li, Jing Liu, Charles M. Balch, Ning Liao

18.07.2020 | Preclinical study | Ausgabe 2/2020

CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ

Marina A. Guvakova, Indira Prabakaran, Zhengdong Wu, Daniel I. Hoffman, Ye Huang, Julia Tchou, Paul J. Zhang

03.07.2020 | Clinical trial | Ausgabe 2/2020

Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer

C. Criscitiello, A. Vingiani, P. Maisonneuve, G. Viale, G. Viale, G. Curigliano

06.07.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Clinical decision trees support systematic evaluation of multidisciplinary team recommendations

Mathijs P. Hendriks, Xander A. A. M. Verbeek, Jeannette G. van Manen, Sannah E. van der Heijden, Shirley H. L. Go, Gea A. Gooiker, Thijs van Vegchel, Sabine Siesling, Agnes Jager

06.07.2020 | Clinical trial | Ausgabe 2/2020

Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients

Adrienne E. Borrie, Finnley A. Rose, Yun-Hee Choi, Francisco E. Perera, Nancy Read, Tracy Sexton, Michael Lock, Theodore A. Vandenberg, Karin Hahn, Jawaid Younus, Diane Logan, Kylea Potvin, Brian Yaremko, Edward Yu, John Lenehan, Stephen Welch, Wendy A. Teft, Richard B. Kim

09.07.2020 | Clinical trial | Ausgabe 2/2020

External validation and modification of nomogram for predicting positive resection margins before breast conserving surgery

Ji-Jung Jung, Eunyoung Kang, Eun-Kyu Kim, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Hee-Chul Shin

09.07.2020 | Clinical trial | Ausgabe 2/2020

Assessing preferences for receiving supportive care resources among patients seen at a Breast Care Center

Emily C. Wong, Celia P. Kaplan, Mikela Barulich, Michelle Melisko

10.07.2020 | Clinical trial | Ausgabe 2/2020

Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation

Shagun Misra, Grace Lee, Yasmin Korzets, Lisa Wang, Anthea Lau, Christine Anne Koch, Jennifer Croke, Joelle Helou

12.07.2020 | Clinical trial | Ausgabe 2/2020

The shape of breast cancer

Brook K. Byrd, Venkataramanan Krishnaswamy, Jiang Gui, Timothy Rooney, Rebecca Zuurbier, Kari Rosenkranz, Keith Paulsen, Richard J. Barth Jr

15.07.2020 | Clinical trial | Ausgabe 2/2020

Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer

Bahar Moftakhar, Manidhar Lekkala, Myla Strawderman, Tae C. Smith, Philip Meacham, Bryan Fitzgerald, Carla I. Falkson, Ajay Dhakal

18.07.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)

Richard S. Finn, Katalin Boer, Igor Bondarenko, Ravindranath Patel, Tamas Pinter, Marcus Schmidt, Yaroslav V. Shparyk, Anu Thummala, Nataliia Voitko, Eustratios Bananis, Lynn McRoy, Keith Wilner, Xin Huang, Sindy Kim, Dennis J. Slamon, Johannes Ettl

09.07.2020 | Epidemiology | Ausgabe 2/2020

Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database

Zhong-Li Du, Yang Wang, Ding-Yuan Wang, Li Zhang, Zhi-Min Bian, Ying Deng, Cheng-Shan Xu, Dong-Cai Lin, Li Xie, Yao Jia, Ji-Dong Gao, Bai-Lin Zhang

10.07.2020 | Epidemiology | Ausgabe 2/2020

Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

Milena Sant, Elisabetta Meneghini, Joana Bastos, Paolo Giorgi Rossi, Marcela Guevara, Kaire Innos, Alexander Katalinic, Leire Gil Majuelo, Rafael Marcos-Gragera, Florence Molinié, Elisabetta Rapiti, Ana Vizcaino, Vesna Zadnik, Pamela Minicozzi, the European High Resolution Working Group on breast cancer

15.07.2020 | Epidemiology | Ausgabe 2/2020

“Are changes in breast density during the menstrual cycle relevant? To what?”

Jean L. Browne, Natalie Korsun, Lilian Casas, Ignacio Rodriguez, Beatriz Valero, Andreina Rincon, M. Angela Pascual

16.07.2020 | Epidemiology | Ausgabe 2/2020

Racial differences in the relationship between surgical choice and subsequent patient-reported satisfaction outcomes among women with early-stage hormone-positive breast cancer

Prudvi Arabandi, Alexander N. Slade, Arnethea L. Sutton, Kandace P. McGuire, Vanessa Sheppard

20.07.2020 | Epidemiology | Ausgabe 2/2020

Obesity and related conditions and risk of inflammatory breast cancer: a nested case–control study

Catherine Schairer, Cecile A. Laurent, Lisa M. Moy, Gretchen L. Gierach, Neil E. Caporaso, Ruth M. Pfeiffer, Lawrence H. Kushi

09.07.2020 | Brief Report | Ausgabe 2/2020

Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials

Kyaw Zin Thein, Thura Win Htut, Somedeb Ball, Sriman Swarup, Anita Sultan, Thein Hlaing Oo

09.07.2020 | Letter to the Editor | Ausgabe 2/2020

Variation in pathological complete response in HER2-positive breast cancers with intrinsic subtypes assessed by PAM50 testing: secondary analysis from NSABP B-41 trial

Arun Kumar Goel, Vaishali Zamre, Shreebha Hari

08.07.2020 | Correction | Ausgabe 2/2020

Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Blanche P. Alter, Ana F. Best

14.07.2020 | Correction | Ausgabe 2/2020

Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

Ahrong Ham, Min Hwan Kim, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joohyuk Sohn

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise